107 related articles for article (PubMed ID: 32961390)
1. Incremental burden of mental health conditions in adult patients with focal seizures.
Petrilla AA; Sutton BS; Leinwand BI; Parente A; Ferrari L; Wade CT
Epilepsy Behav; 2020 Nov; 112():107426. PubMed ID: 32961390
[TBL] [Abstract][Full Text] [Related]
2. Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Schabert VF; Stern S; Ferrari L; Wade CT; Willke RJ; Hauser WA
Epilepsy Behav; 2022 Sep; 134():108865. PubMed ID: 35952507
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
Chen SY; Wu N; Boulanger L; Sacco P
J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
[TBL] [Abstract][Full Text] [Related]
5. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
6. The Humanistic and Economic Burden of Pediatric Focal Seizures in the United States.
Gibbs SN; Choi J; Khilfeh I; Ahmed KH; Yermilov I; Segal E
J Child Neurol; 2020 Jul; 35(8):543-555. PubMed ID: 32223583
[TBL] [Abstract][Full Text] [Related]
7. Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
Qureshi ZP; Thiel E; Nelson J; Khandker R
J Alzheimers Dis; 2021; 83(4):1679-1690. PubMed ID: 34420974
[TBL] [Abstract][Full Text] [Related]
8. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
[TBL] [Abstract][Full Text] [Related]
9. Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey.
Gupta S; Kwan P; Faught E; Tsong W; Forsythe A; Ryvlin P
Epilepsy Behav; 2016 Feb; 55():146-56. PubMed ID: 26773686
[TBL] [Abstract][Full Text] [Related]
10. Budget impact of perampanel as adjunctive treatment of uncontrolled partial-onset and primary generalized tonic-clonic seizures in the United States.
Tremblay G; Barghout V; Patel V; Tsong W; Wang Z
Epilepsy Behav; 2017 Mar; 68():196-202. PubMed ID: 28236697
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
13. Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases.
Broder MS; Greene M; Chang E; Hartry A; Touya M; Munday J; Yan T
Clin Ther; 2018 Oct; 40(10):1670-1682. PubMed ID: 30193748
[TBL] [Abstract][Full Text] [Related]
14. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
15. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Tudur Smith C
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients.
Boulanger L; Zhao Y; Bao Y; Russell MW
BMC Health Serv Res; 2009 Jun; 9():111. PubMed ID: 19566952
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database.
Brook RA; Rajagopalan K; Smeeding JE
Am Health Drug Benefits; 2018 Nov; 11(8):396-403. PubMed ID: 30647827
[TBL] [Abstract][Full Text] [Related]
20. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]